FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Wingard

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
B Wirk; John R Wingard; Jan S Moreb
Extramedullary disease in plasma cell myeloma: the iceberg phenomenon.
Mary Mansour Riwes; John R Wingard
Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies.
John R Wingard
Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Wingard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: B Wirk; John R Wingard; Jan S Moreb
Extramedullary disease in plasma cell myeloma: the iceberg phenomenon.
Bone marrow transplantation 2013;48(1):10-8.
2012: Mary Mansour Riwes; John R Wingard
Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies.
Expert review of hematology 2012;5(6):661-9.
2012: John R Wingard
Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?
Best practice & research. Clinical haematology 2012;25(4):487-91.
2012: Karen Ballen; Vicki Boussiotis; Corey Cutler; Colleen Delaney; Bimalangshu R Dey; Vincent T Ho; Katarzyna Jamieson; Ram Kamble; John Koreth; Richard T Maziarz; Steven McAfee; Philip McCarthy; Adam M Mendizabal; Ioannis Politikos; Elizabeth J Shpall; Robert Soiffer; Thomas R Spitzer; John R Wingard; Edwin Alyea; Eyal C Attar; David Avigan; Edward D Ball; Joseph H Antin
Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(12):1851-8.
2012: Emma H Rosenau; William Slayton; Michele W Sugrue; Myron Chang; Christopher R Cogle; Lamis Eldjerou; Diann Fisk; Michael Haller; Wei Hou; Susan S Kelly; John R Wingard
Characteristics of thawed autologous umbilical cord blood.
Transfusion 2012;52(10):2234-42.
2012: Maxim Norkin; John R Wingard
Armed killers face off against cytomegalovirus.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(7):977-8.
2012: Karen K Ballen; Deepika Bhatla; Reggie Duerst; Steven Joffe; John P Klein; Joanne Kurtzberg; Hillard M Lazarus; Stephanie J Lee; Charles F LeMaistre; Phillip McCarthy; Paulette Mehta; Jeanne Palmer; Susan K Parsons; Tanya L Pedersen; J Douglas Rizzo; Michelle Setterholm; Galen E Switzer; John R Wingard; Navneet S Majhail
Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(6):903-12.
2011: Baldeep Wirk; John R Wingard
Assessing responses to treatment of opportunistic mycoses and salvage strategies.
Current infectious disease reports 2011;13(6):492-503.
2011: Michelle M Bishop; Barbara A Curbow; Jocelyn A Lee; Shauna H Springer; John R Wingard
Comparison of lasting life changes after cancer and BMT: perspectives of long-term survivors and spouses.
Psycho-oncology 2011;20(9):926-34.
2011: John R Wingard; Navneet S Majhail; Ruta Brazauskas; Zhiwei Wang; Kathleen A Sobocinski; David Jacobsohn; Mohamed L Sorror; mary m horowitz; Brian Bolwell; J Douglas Rizzo; Gérard Socié
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(16):2230-9.
2011: John R Wingard; Jack Hsu; John W Hiemenz
Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.
Hematology/oncology clinics of North America 2011;25(1):101-16.
2011: Navneet S Majhail; Ruta Brazauskas; J Douglas Rizzo; Ronald M Sobecks; Zhiwei Wang; Mary M Horowitz; Brian J Bolwell; John R Wingard; Gerard Socie
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.
Blood 2011;117(1):316-22.
2010: John R Wingard; Shelly L Carter; THOMAS WALSH; Joanne Kurtzberg; Trudy N Small; Lindsey R Baden; Iris D Gersten; Adam M Mendizabal; Helen L Leather; Dennis L Confer; Richard T Maziarz; Edward A Stadtmauer; Javier Bolaños-Meade; Janice Brown; John F Dipersio; Michael Boeckh; Kieren Marr
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
Blood 2010;116(24):5111-8.
2010: John R Wingard; I-Chan Huang; Kathleen A Sobocinski; Michael A Andrykowski; David Cella; J Douglas Rizzo; Marianne Brady; Mary M Horowitz; Michelle M Bishop
Factors associated with self-reported physical and mental health after hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(12):1682-92.
2010: Deidre Byrnes Pereira; Lisa M Christian; Seema Patidar; Michelle M Bishop; Stacy M Dodd; Rebecca Athanason; John R Wingard; Vijay S Reddy
Spiritual absence and 1-year mortality after hematopoietic stem cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(8):1171-9.
2010: Amar Safdar; Jonathan Ma; Fouzi Saliba; Bertrand Dupont; John R Wingard; Ray Y Hachem; Gloria N Mattiuzzi; Pranatharthi H Chandrasekar; Dimitrios P Kontoyiannis; Kenneth V Rolston; THOMAS WALSH; Richard E Champlin; Issam I Raad
Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.
Medicine 2010;89(4):236-44.
2010: John R Wingard; Jack Hsu; John W Hiemenz
Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.
Infectious disease clinics of North America 2010;24(2):257-72.
2010: Michelle M Bishop; Stephanie J Lee; Jennifer L Beaumont; Michael A Andrykowski; J Douglas Rizzo; Kathleen A Sobocinski; John R Wingard
The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(2):207-14.
2010: Christopher R Cogle; Iman Imanirad; Laura E Wiggins; Jack Hsu; Randy Brown; Juan C Scornik; John R Wingard
Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.
Clinical advances in hematology & oncology : H&O 2010;8(1):40-6.
2010: C Cable; M P Buzzeo; jesse schold; S Khan; Helen L Leather; Jan S Moreb; K Jamieson; Juan C Scornik; Robert J. Amdur; John R Wingard; Vijay Reddy
Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT.
Bone marrow transplantation 2010;45(1):31-7.
2009: Baldeep Wirk; John R Wingard
Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients.
Mycopathologia 2009;168(6):299-311.
2009: Michael J Haller; clive wasserfall; Kieran M McGrail; Miriam Cintron; Todd Brusko; John R Wingard; Susan S Kelly; Jonathan J Shuster; Mark A Atkinson; Desmond A Schatz
Autologous umbilical cord blood transfusion in very young children with type 1 diabetes.
Diabetes care 2009;32(11):2041-6.
2009: John R Wingard; Mohamed Elmongy
Strategies for minimizing complications of neutropenia: prophylactic myeloid growth factors or antibiotics.
Critical reviews in oncology/hematology 2009;72(2):144-54.
2009: Kieren Marr; E Bow; T Chiller; G Maschmeyer; P Ribaud; B Segal; W Steinbach; John R Wingard; M Nucci
Fungal infection prevention after hematopoietic cell transplantation.
Bone marrow transplantation 2009;44(8):483-7.
2009: Amin Alousi; Daniel J Weisdorf; Brent R Logan; F. JAVIER BOLANOS MEADE; Shelly Carter; DiFronzo Nancy; Marcelo Pasquini; Steven C Goldstein; Vincent T Ho; Brandon Hayes-Lattin; John R Wingard; Mary M Horowitz; John E Levine
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.
Blood 2009;114(3):511-7.
2009: Roy B Jones; Yago Nieto; Donna Wall; John R Wingard; J Douglas Rizzo; Philip L McCarthy; Denise Oliansky; Theresa Hahn
Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):761-2.
2009: Paul J Martin; Barry E Storer; Scott D Rowley; Mary E D Flowers; Stephanie J Lee; Paul A Carpenter; John R Wingard; Paul J Shaughnessy; Marcel P Devetten; Madan Jagasia; Joseph W Fay; Koen van Besien; Vikas Gupta; Carrie L Kitko; Laura J Johnston; Richard T Maziarz; Mukta Arora; Pamala A Jacobson; Daniel Weisdorf
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
Blood 2009;113(21):5074-82.
2009: B Wirk; John R Wingard
Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(2):143-8.
2009: J Douglas Rizzo; Rochelle E Curtis; Gérard Socié; Kathleen A Sobocinski; Ethel Gilbert; Ola Landgren; Lois B Travis; William D Travis; Mary E D Flowers; Debra L Friedman; Mary M Horowitz; John R Wingard; H Joachim Deeg
Solid cancers after allogeneic hematopoietic cell transplantation.
Blood 2009;113(5):1175-83.
2008: Baldeep Wirk; John R Wingard
Combination antifungal therapy: from bench to bedside.
Current infectious disease reports 2008;10(6):466-72.
2008: Xiao-Miao Li; Zhongbo Hu; Marda L Jorgenson; John R Wingard; William B Slayton
Bone marrow sinusoidal endothelial cells undergo nonapoptotic cell death and are replaced by proliferating sinusoidal cells in situ to maintain the vascular niche following lethal irradiation.
Experimental hematology 2008;36(9):1143-1156.
2008: Brahm H Segal; Raoul Herbrecht; David A Stevens; Luis Ostrosky-Zeichner; Jack D Sobel; Claudio Viscoli; THOMAS WALSH; Johan Maertens; Thomas Patterson; John R Perfect; Bertrand Dupont; John R Wingard; Thierry Calandra; Carol A Kauffman; John Graybill; Lindsey R Baden; Peter G Pappas; JOHN BENNETT; Dimitrios P Kontoyiannis; Catherine Cordonnier; Maria Anna Viviani; Jacques Bille; Nikolaos G Almyroudis; L Joseph Wheat; Wolfgang Graninger; Eric J Bow; Steven M Holland; Bart Jan Kullberg; William E Dismukes; Ben E De Pauw
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(5):674-83.
2008: John R Wingard; Patricia Ribaud; Haran T Schlamm; Raoul Herbrecht
Changes in causes of death over time after treatment for invasive aspergillosis.
Cancer 2008;112(10):2309-12.
2008: John R Wingard
Learning from our failures: the antifungal treatment conundrum.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(9):1434-5.
2008: Cornelius J Clancy; Minh-Ly Nguyen; Shaoji Cheng; Hong Huang; Guixiang Fan; Reia A Jaber; John R Wingard; Christina Cline; minh nguyen
Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis.
Journal of clinical microbiology 2008;46(5):1647-54.
2008: Hitoshi Minamiguchi; Fumihiko Ishikawa; Paul A Fleming; Su Yang; Christopher J Drake; John R Wingard; Makio Ogawa
Transplanted human cord blood cells generate amylase-producing pancreatic acinar cells in engrafted mice.
Pancreas 2008;36(2):e30-5.
2008: John R Wingard
Influenza: preparedness for an inevitable "Emergency" for oncology and BMT units.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(2):215-22.
2008: THOMAS WALSH; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne H van Burik; John R Wingard; Thomas Patterson
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(3):327-60.
2007: Mary Eapen; Brent R Logan; Dennis L Confer; Michael Haagenson; John E Wagner; Daniel J Weisdorf; John R Wingard; Scott D Rowley; David Stroncek; Adrian P Gee; Mary M Horowitz; Claudio Anasetti
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1461-8.
2007: William B Slayton; Xiao-Miao Li; Jason Butler; Steven M Guthrie; Marda L Jorgensen; John R Wingard; Edward W Scott
The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplant.
Stem cells (Dayton, Ohio) 2007;25(11):2945-55.
2007: Xiao-Miao Li; Zhongbo Hu; Martha C Sola-Visner; Stacey Hensel; Rachel Garner; Abu-Bakr Zafar; John R Wingard; Marda L Jorgensen; Robert C Fisher; Edward W Scott; William B Slayton
Sites and kinetics of donor thrombopoiesis following transplantation of whole bone marrow and progenitor subsets.
Experimental hematology 2007;35(10):1567-79.
2007: Thomas Adamkiewicz; Paul Szabolcs; Ann Haight; K Scott Baker; Susan Staba; Amos Kedar; Kuang-Yueh Chiang; Lakshmanan Krishnamurti; Michael W Boyer; Joan Kurtzberg; John E Wagner; John R Wingard; Andrew M Yeager
Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience.
Pediatric transplantation 2007;11(6):641-4.
2007: John R Wingard; Raoul Herbrecht; Josephine Mauskopf; Haran T Schlamm; Anne Marciniak; C S Roberts
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Transplant infectious disease : an official journal of the Transplantation Society 2007;9(3):182-8.
2007: minh nguyen; Reia Jaber; Helen L Leather; John R Wingard; Benjamin Staley; L Joseph Wheat; Christina L Cline; Maher A Baz; Kenneth H Rand; Cornelius J Clancy
Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.
Journal of clinical microbiology 2007;45(9):2787-92.
2007: Cornelius J Clancy; Reia A Jaber; Helen L Leather; John R Wingard; Benjamin Staley; L Joseph Wheat; Christina L Cline; Kenneth H Rand; Denise Schain; Maher A Baz; minh nguyen
Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.
Journal of clinical microbiology 2007;45(6):1759-65.
2007: Michelle M Bishop; Jennifer L Beaumont; Elizabeth A Hahn; David Cella; Michael A Andrykowski; Marianne J Brady; Mary M Horowitz; Kathleen A Sobocinski; J Douglas Rizzo; John R Wingard
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1403-11.
2007: John R Wingard; Helen L Leather; Craig A Wood; William C Gerth; Robert J Lupinacci; Marc L Berger; Edward C Mansley
Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007;64(6):637-43.
2007: John R Wingard
New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patients.
Best practice & research. Clinical haematology 2007;20(1):99-107.
2007: Mark E Ignatz; Martha C Sola-Visner; Lisa M Rimsza; Debra Fuchs; Jonathan J Shuster; Xiao-Miao Li; Anil Jotwani; Susan Staba; John R Wingard; Zhongbo Hu; William B Slayton
Umbilical cord blood produces small megakaryocytes after transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(2):145-50.
2007: William W Hope; Michael J Kruhlak; Caron A Lyman; Ruta Petraitiene; Vidmantas Petraitis; Andrea Francesconi; Miki Kasai; Diana Mickiene; Tin Sein; Joanne Peter; Amy M Kelaher; Johanna E Hughes; Margaret P Cotton; Catherine J Cotten; John Bacher; Sanjay Tripathi; Louis Bermudez; Timothy K Maugel; Patricia M Zerfas; John R Wingard; George L Drusano; THOMAS WALSH
Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.
The Journal of infectious diseases 2007;195(3):455-66.
2007: Reginald E Greene; Haran T Schlamm; Jörg Oestmann; Paul Stark; Christine Durand; Olivier Lortholary; John R Wingard; Raoul Herbrecht; Patricia Ribaud; Thomas Patterson; Peter Troke; David W Denning; JOHN BENNETT; Ben E de Pauw; Robert Rubin
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(3):373-9.
2006: John R Wingard; Alan K Leahigh; Dennis Confer; John Edwards; Rocky L Billups; Marcel R M van den Brink; Armand Keating
Preparing for the unthinkable: emergency preparedness for the hematopoietic cell transplant program.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(11):1229-38.
2006: Thomas J George; Michele W Sugrue; Sarah N George; John R Wingard
Factors associated with parameters of engraftment potential of umbilical cord blood.
Transfusion 2006;46(10):1803-12.
2006: Helen L Leather; John R Wingard
New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.
Blood reviews 2006;20(5):267-87.
2006: Helen L Leather; John R Wingard
Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients?
Current opinion in infectious diseases 2006;19(4):371-9.
2006: Helen Leather; Renee M Boyette; Lili Tian; John R Wingard
Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(3):325-34.
2006: J Douglas Rizzo; John R Wingard; André Tichelli; Su-Jun Lee; Maria Teresa Van Lint; Linda J Burns; Stella M Davies; James L M Ferrara; Gérard Socié
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):138-51.
2006: J Douglas Rizzo; John R Wingard; André Tichelli; Su-Jun Lee; M T Van Lint; Linda J Burns; Stella M Davies; James L M Ferrara; Gérard Socié
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
Bone marrow transplantation 2006;37(3):249-61.
2005: Vijay Reddy; Andrew G Winer; Erika Eksioglu; Herwig-Ulf Meier-Kriesche; jesse schold; John R Wingard
Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):1014-21.
2005: Thomas Patterson; Helen W Boucher; Raoul Herbrecht; David W Denning; Olivier Lortholary; Patricia Ribaud; Robert Rubin; John R Wingard; Ben DePauw; Haran T Schlamm; Peter Troke; JOHN BENNETT
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(10):1448-52.
2005: Helen L Leather; Todd A Correll; Christine L Meyer; Ilona M Schmalfuss; John R Wingard
Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.
Clinical advances in hematology & oncology : H&O 2005;3(10):773-7.
2005: William B Slayton; David A Wainman; Xiao Miao Li; Zhongbo Hu; Anil Jotwani; Christopher R Cogle; Danielle Walker; Robert C Fisher; John R Wingard; Edward W Scott; Martha C Sola
Developmental differences in megakaryocyte maturation are determined by the microenvironment.
Stem cells (Dayton, Ohio) 2005;23(9):1400-8.
2005: Vijay Reddy; Herwig-Ulf Meier-Kriesche; Samantha Greene; jesse schold; John R Wingard
Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):698-705.
2005: John R Wingard; Craig A Wood; Elizabeth Sullivan; Marc L Berger; William C Gerth; Edward C Mansley
Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis.
Clinical therapeutics 2005;27(6):960-9.
2005: John R Wingard
The changing face of invasive fungal infections in hematopoietic cell transplant recipients.
Current opinion in oncology 2005;17(2):89-92.
2005: Michael A Andrykowski; Michelle M Bishop; Elizabeth A Hahn; David Cella; Jennifer L Beaumont; Marianne J Brady; Mary M Horowitz; Kathleen A Sobocinski; J Douglas Rizzo; John R Wingard
Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):599-608.
2004: John R Wingard
Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39 Suppl 4():S176-80.
2004: Thomas Adamkiewicz; P S Mehta; Michael W Boyer; A Kedar; T A Olson; Ellen Olson; Kuang-Yueh Chiang; D Maurer; MJ Mogul; John R Wingard; Andrew M Yeager
Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease.
Bone marrow transplantation 2004;34(5):405-11.
2004: John R Wingard
Empirical antifungal therapy in treating febrile neutropenic patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39 Suppl 1():S38-43.
2004: Francis Giles; Roberto Rodriguez; Daniel Weisdorf; John R Wingard; Paul J Martin; Thomas R Fleming; Stuart L Goldberg; Elias J Anaissie; Brian J Bolwell; Nelson J Chao; Thomas C Shea; Mark M Brunvand; William Vaughan; Finn Petersen; Mark Schubert; Hillard M Lazarus; Richard T Maziarz; Margarida Silverman; Roy A Beveridge; Rebecca Redman; Janis G Pulliam; Patricia Devitt-Risse; Henry J Fuchs; David D Hurd
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
Leukemia research 2004;28(6):559-65.
2004: Vijay Reddy; Jose A Iturraspe; Alessandra C Tzolas; Herwig-Ulf Meier-Kriesche; jesse schold; John R Wingard
Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease.
Blood 2004;103(11):4330-5.
2004: Christopher R Cogle; Anthony T Yachnis; Eric D Laywell; Dani S Zander; John R Wingard; Dennis A Steindler; Edward W Scott
Bone marrow transdifferentiation in brain after transplantation: a retrospective study.
Lancet 2004;363(9419):1432-7.
2004: Michelle M Bishop; John R Wingard
Thriving after hematopoietic stem cell transplant: a focus on positive changes in quality of life.
Expert review of pharmacoeconomics & outcomes research 2004;4(1):111-23.
2004: John R Wingard; Helen Leather
A new era of antifungal therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):73-90.
2004: John R Wingard; W Garrett Nichols; George B McDonald
Supportive care.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():372-89.
2004: Barbara Shea; Vijay Reddy; Patricia Abbitt; Rashmi K Benda; Vonda K Douglas; John R Wingard
Granulocytic sarcoma (chloroma) of the breast: a diagnostic dilemma and review of the literature.
The breast journal 2004;10(1):48-53.
2003: Borje S Andersson; Ashwin Kashyap; Daniel Couriel; Timothy Madden; Marcos De Lima; Peter F Thall; Hugo Fernandez; William Vaughan; Roy Jones; John R Wingard; Karl G Blume; Richard E Champlin
Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(11):722-4.
2003: David Cella; Janis G Pulliam; Henry Fuchs; Carole B Miller; David D Hurd; John R Wingard; Stephen T Sonis; Paul J Martin; Francis Giles
Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy.
Cancer 2003;98(2):406-12.
2003: Francis Giles; Carole B Miller; David D Hurd; John R Wingard; Thomas R Fleming; Stephen T Sonis; Williamson Z Bradford; Janis G Pulliam; Elias J Anaissie; Roy A Beveridge; Mark M Brunvand; Paul J Martin
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
Leukemia & lymphoma 2003;44(7):1165-72.
2003: Christopher R Cogle; Jan S Moreb; Helen L Leather; Katarzyna J Finiewicz; Shahab A Khan; Vijay S Reddy; John R Wingard
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma.
American journal of hematology 2003;73(3):169-75.
2003: Christopher R Cogle; Rebecca M Minter; Christine L Meyers; W Robert Rout; John R Wingard
Typhlitis with concurrent appendicitis in a patient with chronic lymphocytic leukemia.
Clinical advances in hematology & oncology : H&O 2003;1(5):284-6; discussion 286.
2003: Lucio N Gordan; MW Sugrue; James W Lynch; K D Williams; Shahab A Khan; John R Wingard; Jan S Moreb
Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation.
Leukemia & lymphoma 2003;44(5):815-20.
2003: Paulette Mehta; Bradley Pollock; Melodee Nugent; Mary Horowitz; John R Wingard
Access to stem cell transplantation: do women fare as well as men?
American journal of hematology 2003;72(2):99-102.
2002: Raleigh Bowden; Pranatharthi H Chandrasekar; Mary H White; Xin Li; Larry Pietrelli; Marc Gurwith; Jo-Anne H van Burik; Michel Laverdiere; Sharon Safrin; John R Wingard
A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(4):359-66.
2002: Raoul Herbrecht; David W Denning; Thomas Patterson; JOHN BENNETT; Reginald E Greene; Jörg Oestmann; Winfried V Kern; Kieren Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter Troke; Ben de Pauw
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
The New England journal of medicine 2002;347(6):408-15.
2002: Helen L Leather; John R Wingard
Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?
Current opinion in infectious diseases 2002;15(4):369-75.
2002: Michelle M Bishop; J R Rodrigue; John R Wingard
Mismanaging the gift of life: noncompliance in the context of adult stem cell transplantation.
Bone marrow transplantation 2002;29(11):875-80.
2002: John R Wingard
Antifungal chemoprophylaxis after blood and marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(10):1386-90.
2002: Mark G Mainwaring; Lisa M Rimsza; S F Chen; S P Gomez; F W Weeks; V Reddy; J Lynch; W Stratford May; S Kahn; Jan S Moreb; Helen L Leather; Raul C Braylan; Thomas C Rowe; K J Fieniewicz; John R Wingard
Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels.
Leukemia & lymphoma 2002;43(5):989-99.
2002: THOMAS WALSH; Peter Pappas; Drew J Winston; Hillard M Lazarus; Finn Petersen; John Raffalli; Saul Yanovich; Patrick J Stiff; Richard Greenberg; Gerald R Donowitz; Mindy Schuster; Annette C Reboli; John R Wingard; Carola Arndt; John Reinhardt; Susan Hadley; Robert Finberg; Michél Laverdière; John R Perfect; Gary Garber; Giuseppe Fioritoni; Eli Anaissie; Jeanette Lee
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
The New England journal of medicine 2002;346(4):225-34.
2002: Marc S Zumberg; Helen L Leather; Christine F Nejame; C Meyer; John R Wingard
GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation.
Cytotherapy 2002;4(6):531-8.
2002: John R Wingard; Georgia B Vogelsang; H Joachim Deeg
Stem cell transplantation: supportive care and long-term complications.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():422-44.
2002: Marc S Zumberg; Maria Luz U del Rosario; Christine F Nejame; Bradley Pollock; Linda Garzarella; Kuo-Jang Kao; Richard Lottenberg; John R Wingard
A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(10):569-76.
2002: Ashwin Kashyap; John R Wingard; Pablo J Cagnoni; Jones Roy; stefano r tarantolo; Wendy Hu; Karl G Blume; Joyce C Niland; Joycelynne M Palmer; William Vaughan; Hugo Fernandez; Richard Champlin; Stephen Forman; Borje S Andersson
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):493-500.
2002: Borje S Andersson; Ashwin Kashyap; Victor Gian; John R Wingard; Hugo Fernandez; Pablo J Cagnoni; Roy B Jones; stefano r tarantolo; Wendy W Hu; Karl G Blume; Stephen J Forman; Richard E Champlin
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):145-54.
2002: W B Grow; Jan S Moreb; D Roque; K Manion; Helen L Leather; V Reddy; Shahab A Khan; K J Finiewicz; H Nguyen; Cornelius J Clancy; P S Mehta; John R Wingard
Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
Bone marrow transplantation 2002;29(1):15-9.
2001: B A Collin; Helen L Leather; John R Wingard; Reuben Ramphal
Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(7):947-53.
2001: Drew J Winston; Joseph H Antin; Steven Neil Wolff; B E Bierer; Trudy N Small; K B Miller; Charles Linker; H Kaizer; Hillard M Lazarus; Finn Bo Petersen; M J Cowan; WG Ho; John R Wingard; Gary J Schiller; Mary Territo; J Jiao; M A Petrarca; S A Tonetta
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Bone marrow transplantation 2001;28(2):187-96.
2001: D A Eagle; Victor Gian; G Y Lauwers; J C Manivel; Jan S Moreb; Suzanne T Mastin; John R Wingard
Gastroparesis following bone marrow transplantation.
Bone marrow transplantation 2001;28(1):59-62.
2001: S Sharda; J Carter; John R Wingard; Paulette Mehta
Monitoring vital signs in a bone marrow transplant unit: are they needed in the middle of the night?
Bone marrow transplantation 2001;27(11):1197-200.
2001: Helen L Leather; John R Wingard
Infections following hematopoietic stem cell transplantation.
Infectious disease clinics of North America 2001;15(2):483-520.
2001: John R Wingard; Helen L Leather
Empiric antifungal therapy for the neutropenic patient.
Oncology (Williston Park, N.Y.) 2001;15(3):351-63; discussion 363-4, 367-9.
2001: Suzanne Skoda-Smith; Vonda K Douglas; Paulette Mehta; John Graham-Pole; John R Wingard
Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab.
Bone marrow transplantation 2001;27(3):329-32.
2001: S A Khan; B Gaa; Bradley Pollock; B Shea; Vijay Reddy; John R Wingard; Jan S Moreb
Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(8):433-8.
2000: MW Sugrue; K Williams; Bradley Pollock; S Khan; S Peracha; John R Wingard; Jan S Moreb
Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation.
Leukemia & lymphoma 2000;39(5-6):509-19.
2000: John R Wingard; M H White; E Anaissie; John Raffalli; J Goodman; A Arrieta
A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1155-63.
2000: Borje S Andersson; James L Gajewski; Michele Donato; Sergio Giralt; Victor Gian; John R Wingard; stefano r tarantolo; Hugo Fernandez; Wendy W Hu; Karl G Blume; Ashwin Kashyap; Stephen J Forman; Richard E Champlin
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy).
Bone marrow transplantation 2000;25 Suppl 2():S35-8.
2000: Cornelius J Clancy; John R Wingard; M Hong Nguyen
Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2000;38(2):169-75.
2000: Paulette Mehta; J Rodrigue; Christine F Nejame; R Gaa; John R Wingard
Acquiescence to adjunctive experimental therapies may relate to psychological distress: pilot data from a bone marrow transplant center.
Bone marrow transplantation 2000;25(6):673-6.
1999: Paulette Mehta; S Beltz; Amos Kedar; John Graham-Pole; John R Wingard
Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation.
Bone marrow transplantation 1999;24(12):1323-7.
1999: John R Wingard; P Kubilis; L Lee; G Yee; M White; L Walshe; R Bowden; E Anaissie; John W Hiemenz; J Lister
Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(6):1402-7.
1999: Donna Przepiorka; S Devine; J Fay; Joseph Primo Uberti; John R Wingard
Practical considerations in the use of tacrolimus for allogeneic marrow transplantation.
Bone marrow transplantation 1999;24(10):1053-6.
1999: John M Waples; Jan S Moreb; MW Sugrue; G Belanger; P Kubilis; James W Lynch; Victor Gian; FM Weeks; John R Wingard
Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight.
Bone marrow transplantation 1999;23(9):867-73.
1999: Paulette Mehta; Amos Kedar; John Graham-Pole; Suzanne Skoda-Smith; John R Wingard
Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature.
Pediatrics 1999;103(4):e44.
1999: John R Wingard
Opportunistic infections after blood and marrow transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 1999;1(1):3-20.
1999: Mary M Horowitz; Donna Przepiorka; P Bartels; Donald N Buell; Mei-Jie Zhang; William E Fitzsimmons; J Erdman; C Huang; E Hodosh; Rochelle M Maher; John R Wingard
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(3):180-6.
1999: Donna Przepiorka; Richard A Nash; John R Wingard; J Zhu; Rochelle M Maher; William E Fitzsimmons; Joseph W Fay
Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(2):94-7.
1999: John R Wingard
Fungal infections after bone marrow transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(2):55-68.
1998: M J Camp; John R Wingard; C E Gilmore; L S Lin; SP Dix; T G Davidson; RB Geller
Efficacy of low-dose dopamine in preventing amphotericin B nephrotoxicity in bone marrow transplant patients and leukemia patients.
Antimicrobial agents and chemotherapy 1998;42(12):3103-6.
1998: C L Osowski; SP Dix; M Lynn; T Davidson; L Cohen; T Miyahara; M C Sexauer; R Joyce; A Yeager; John R Wingard
An open-label dose comparison study of ondansetron for the prevention of emesis associated with chemotherapy prior to bone marrow transplantation.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(6):511-7.
1998: MW Sugrue; CE Hutcheson; D D Fisk; C G Roberts; A Mageed; John R Wingard; Jan S Moreb
The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery, and cost.
Journal of hematotherapy 1998;7(5):431-6.
1998: Voravit Ratanatharathorn; Richard A Nash; Donna Przepiorka; Steven M Devine; Jared L Klein; Daniel Weisdorf; Joseph W Fay; Auayporn Nademanee; Joseph H Antin; Neal Christiansen; R van der Jagt; Roger H Herzig; Mark R Litzow; Steven Neil Wolff; W L Longo; F B Petersen; Chatchada Karanes; Belinda R Avalos; Rainer Storb; Donald N Buell; Rochelle M Maher; William E Fitzsimmons; John R Wingard
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Blood 1998;92(7):2303-14.
1998: Mary H White; Raleigh A Bowden; Eric S Sandler; M L Graham; Gary A Noskin; John R Wingard; M Goldman; Jo-Anne H van Burik; A McCabe; J S Lin; Marc Gurwith; Carole B Miller
Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(2):296-302.
1998: W Hübl; Jose A Iturraspe; G A Martinez; CE Hutcheson; C G Roberts; D D Fisk; MW Sugrue; John R Wingard; Raul C Braylan
Measurement of absolute concentration and viability of CD34+ cells in cord blood and cord blood products using fluorescent beads and cyanine nucleic acid dyes.
Cytometry 1998;34(3):121-7.
1998: Victor Gian; Jan S Moreb; A Abdel-Mageed; FM Weeks; J C Scornick; John R Wingard
Successful salvage using mismatched umbilical cord blood transplant in an adult with recurrent acute myelogenous leukemia failing autologous peripheral blood progenitor cell transplant: a case history and review.
Bone marrow transplantation 1998;21(12):1197-200.
1998: John R Wingard
Quality of life following bone marrow transplantation.
Current opinion in oncology 1998;10(2):108-11.
1998: John R Wingard; Richard A Nash; Donna Przepiorka; Jared L Klein; Daniel J Weisdorf; Joseph W Fay; J Zhu; Rochelle M Maher; William E Fitzsimmons; Voravit Ratanatharathorn
Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):157-63.
1998: GW Boswell; Ihor Bekersky; J Fay; John R Wingard; Joseph H Antin; D Weisdorf; Rochelle M Maher; William E Fitzsimmons; R Nash
Tacrolimus pharmacokinetics in BMT patients.
Bone marrow transplantation 1998;21(1):23-8.
1997: FM Weeks; G C Yee; A A Bartfield; John R Wingard
The true cost of bone marrow transplantation.
The American journal of the medical sciences 1997;314(2):101-12.
1997: RB Geller; Steven M Devine; Kate K O'Toole; L Persons; J Keller; D Mauer; H Kent Holland; SP Dix; M Piotti; Istvan Redei; G Connaghan; Leonard T Heffner; Christopher D Hillyer; Edmond WALLER; Elliott F Winton; John R Wingard
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
Bone marrow transplantation 1997;20(3):219-25.
1997: John R Wingard; Richard A Nash; Voravit Ratanatharathorn; Joseph W Fay; Jared L Klein; Donna Przepiorka; Rochelle M Maher; Steven M Devine; GW Boswell; Ihor Bekersky; William E Fitzsimmons
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients.
Bone marrow transplantation 1997;20(1):49-51.
1997: Steven M Devine; RB Geller; L B Lin; SP Dix; H Kent Holland; D Maurer; Kate K O'Toole; J Keller; D Gerald Connaghan; Leonard T Heffner; Christopher D Hillyer; Glenn Rodey; Elliott F Winton; Rochelle M Maher; William E Fitzsimmons; John R Wingard
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(1):25-33.
1997: Mary H White; Elias J Anaissie; S Kusne; John R Wingard; John W Hiemenz; A Cantor; Marc Gurwith; C Du Mond; RD Mamelok; Raleigh A Bowden
Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(4):635-42.
1997: John R Wingard
Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
Bone marrow transplantation 1997;19(4):343-7.
1997: Istvan Redei; Edmond WALLER; H Kent Holland; Steven M Devine; John R Wingard
Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions.
Bone marrow transplantation 1997;19(2):175-7.
1997: Frederick S. Nolte; T Parkinson; Derek Falconer; SP Dix; J Williams; C Gilmore; Robert J Geller; John R Wingard
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Antimicrobial agents and chemotherapy 1997;41(1):196-9.
1996: Steven M Devine; Nancy J Newman; J L Siegel; GJ Joseph; T C Geis; J A Schneider; RB Geller; John R Wingard
Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation.
Bone marrow transplantation 1996;18(3):569-72.
1996: Michael W Fried; D Gerald Connaghan; S Sharma; Louis G Martin; Steven M Devine; K Holland; A Zuckerman; S Kaufman; John R Wingard; Thomas D Boyer
Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.
Hepatology (Baltimore, Md.) 1996;24(3):588-91.
1996: R K Emmens; D Richardson; W Thomas; S Hunter; Randolph A Hennigar; John R Wingard; Frederick S. Nolte
Necrotizing cerebritis in an allogeneic bone marrow transplant recipient due to Cladophialophora bantiana.
Journal of clinical microbiology 1996;34(5):1330-2.
1996: C L Osowski; SP Dix; L S Lin; R E Mullins; RB Geller; John R Wingard
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.
Transplantation 1996;61(8):1268-72.
1996: Joseph W Fay; John R Wingard; Joseph H Antin; Robert H Collins; L A Piñeiro; B R Blazar; R Saral; B E Bierer; Donna Przepiorka; William E Fitzsimmons; Rochelle M Maher; D J Weisdorf
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.
Blood 1996;87(8):3514-9.
1996: CW Turner; Andrew M Yeager; Edmond WALLER; John R Wingard; William H Fleming
Engraftment potential of different sources of human hematopoietic progenitor cells in BNX Mice.
Blood 1996;87(8):3237-44.
1996: M R Somerfield; B Curbow; John R Wingard; Frank Baker; L A Fogarty
Coping with the physical and psychosocial sequelae of bone marrow transplantation among long-term survivors.
Journal of behavioral medicine 1996;19(2):163-84.
1996: H Kent Holland; SP Dix; RB Geller; Steven M Devine; Leonard T Heffner; D Gerald Connaghan; Christopher D Hillyer; Lorie L Hughes; R L Miller; M R Moore; Elliott F Winton; John R Wingard
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1156-64.
1996: SP Dix; John R Wingard; R E Mullins; I Jerkunica; T G Davidson; C E Gilmore; R C York; L S Lin; Steven M Devine; RB Geller; Leonard T Heffner; Christopher D Hillyer; H Kent Holland; Elliott F Winton; R Saral
Association of busulfan area under the curve with veno-occlusive disease following BMT.
Bone marrow transplantation 1996;17(2):225-30.
1995: A A Abou-Elella; T A Camarillo; M B Allen; S Barclay; J A Pierce; H Kent Holland; John R Wingard; Robert A. Bray; Glenn Rodey; Christopher D Hillyer
Low incidence of red cell and HLA antibody formation by bone marrow transplant patients.
Transfusion 1995;35(11):931-5.
1995: V S Gharpure; Steven M Devine; H Kent Holland; RB Geller; K O'Toole; John R Wingard
Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation.
Bone marrow transplantation 1995;16(5):715-6.
1995: RB Geller; C E Gilmore; SP Dix; L S Lin; D L Topping; T G Davidson; H Kent Holland; John R Wingard
Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
American journal of hematology 1995;50(3):167-72.
1995: T F Neal; H Kent Holland; C M Baum; Francios VILLINGER; Aftab A Ansari; R Saral; John R Wingard; William H Fleming
CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1.
Blood 1995;86(5):1749-56.
1995: J H Deutsch; Patricia A Hudgins; J L Siegel; S B Peterman; Steven M Devine; R York; John R Wingard
The paranasal sinuses of patients with acute graft-versus-host disease.
AJNR. American journal of neuroradiology 1995;16(6):1287-91.
1995: Frederick S. Nolte; R K Emmens; C Thurmond; P S Mitchell; C Pascuzzi; Steven M Devine; R Saral; John R Wingard
Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification.
Journal of clinical microbiology 1995;33(5):1263-6.
1995: Joseph W Fay; R A Nash; John R Wingard; Donna Przepiorka; Robert H Collins; Claudio Anasetti; Steven M Devine; L A Piñeiro; Rainer Storb; R M Aro
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
Transplantation proceedings 1995;27(1):1374.
1995: John R Wingard
Importance of Candida species other than C. albicans as pathogens in oncology patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(1):115-25.
1994: Steven M Devine; John R Wingard
Viral infections in severely immunocompromised cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(6):355-68.
1994: John R Wingard
Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19 Suppl 1():S49-53.
1994: Frank Baker; John R Wingard; B Curbow; James Zabora; D Jodrey; L Fogarty; M Legro
Quality of life of bone marrow transplant long-term survivors.
Bone marrow transplantation 1994;13(5):589-96.
1994: John R Wingard
Functional ability and quality of life of patients after allogeneic bone marrow transplantation.
Bone marrow transplantation 1994;14 Suppl 4():S29-33.
1993: Deborah B McGuire; V Altomonte; D E Peterson; John R Wingard; Richard J Jones; Louise B. Grochow
Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation.
Oncology nursing forum 1993;20(10):1493-502.
1993: B Curbow; M R Somerfield; Frank Baker; John R Wingard; M W Legro
Personal changes, dispositional optimism, and psychological adjustment to bone marrow transplantation.
Journal of behavioral medicine 1993;16(5):423-43.
1993: James P Dunn; Douglas A Jabs; John R Wingard; Cheryl Enger; Georgia B Vogelsang; G Santos
Bone marrow transplantation and cataract development.
Archives of ophthalmology 1993;111(10):1367-73.
1993: John R Wingard
Infections in allogeneic bone marrow transplant recipients.
Seminars in oncology 1993;20(5 Suppl 6):80-7.
1993: John R Wingard; William G Merz; M G Rinaldi; Carole B Miller; Judith E Karp; R Saral
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
Antimicrobial agents and chemotherapy 1993;37(9):1847-9.
1993: Steven M Devine; RB Geller; H Kent Holland; John R Wingard; R Saral
New preparative regimens with diaziquone or cytarabine in combination with busulfan and cyclophosphamide.
Seminars in oncology 1993;20(4 Suppl 4):56-63; quiz 64.
1993: N K Shah; John R Wingard; Steven Piantadosi; S Rowley; G Santos; Constance A Griffin
Chromosome abnormalities in patients treated with 4-hydroperoxycyclophosphamide-purged autologous bone marrow transplantation.
Cancer genetics and cytogenetics 1993;65(2):135-40.
1993: John R Wingard
Viral infections in leukemia and bone marrow transplant patients.
Leukemia & lymphoma 1993;11 Suppl 2():115-25.
1992: John R Wingard
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
Leukemia & lymphoma 1992;8(4-5):353-9.
1992: J E Wagner; Marianna Zahurak; Steven Piantadosi; R B Geller; Georgia B Vogelsang; John R Wingard; R Saral; Constance A Griffin; N Shah; B A Zehnbauer
Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):779-89.
1992: Georgia B Vogelsang; Evan Farmer; Allan Hess; V Altamonte; W E Beschorner; D A Jabs; RUSSELL CORIO; L S Levin; O Michael Colvin; John R Wingard
Thalidomide for the treatment of chronic graft-versus-host disease.
The New England journal of medicine 1992;326(16):1055-8.
1992: John R Wingard; B Curbow; Frank Baker; James Zabora; Steven Piantadosi
Sexual satisfaction in survivors of bone marrow transplantation.
Bone marrow transplantation 1992;9(3):185-90.
1992: A M Yeager; C Shinn; Evan Farmer; John R Wingard; M J Yeager
Growth retardation and depigmentation of hair after high-dose busulfan and congenic hematopoietic cell transplantation in mice.
Bone marrow transplantation 1992;9(3):199-204.
1992: John R Wingard; Leslie P Plotnick; C S Freemer; M Zahurak; Steven Piantadosi; D F Miller; huib vriesendorp; A M Yeager; G W Santos
Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation.
Blood 1992;79(4):1068-73.
1991: John R Wingard; William G Merz; M G Rinaldi; T R Johnson; Judith E Karp; R Saral
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
The New England journal of medicine 1991;325(18):1274-7.
1991: John R Wingard; C S Niehaus; D E Peterson; Richard J Jones; Steven Piantadosi; L S Levin; R Saral; G W Santos
Oral mucositis after bone marrow transplantation. A marker of treatment toxicity and predictor of hepatic veno-occlusive disease.
Oral surgery, oral medicine, and oral pathology 1991;72(4):419-24.
1991: R Avery; Douglas A Jabs; John R Wingard; Georgia B Vogelsang; R Saral; G Santos
Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity.
Ophthalmology 1991;98(8):1294-301.
1991: S D Rowley; Steven Piantadosi; D C Marcellus; Richard J Jones; Nancy E Davidson; JANICE DAVIS SPROUL; J Kennedy; J M Wiley; John R Wingard; A M Yeager
Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Bone marrow transplantation 1991;7(3):183-91.
1991: John R Wingard; B Curbow; Frank Baker; Steven Piantadosi
Health, functional status, and employment of adult survivors of bone marrow transplantation.
Annals of internal medicine 1991;114(2):113-8.
1991: Frank Baker; B Curbow; John R Wingard
Role retention and quality of life of bone marrow transplant survivors.
Social science & medicine (1982) 1991;32(6):697-704.
1990: John R Wingard
Advances in the management of infectious complications after bone marrow transplantation.
Bone marrow transplantation 1990;6(6):371-83.
1990: John R Wingard; Steven Piantadosi; W H Burns; Marianna Zahurak; G W Santos; R Saral
Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy.
Reviews of infectious diseases 1990;12 Suppl 7():S793-804.
1990: John R Wingard; Steven Piantadosi; G W Santos; R Saral; huib vriesendorp; A M Yeager; W H Burns; Richard F Ambinder; Hayden Braine; G Elfenbein
Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):820-30.
1990: H K Holland; John R Wingard; R Saral
Herpesvirus and enteric viral infections in bone marrow transplantation: clinical presentations, pathogenesis, and therapeutic strategies.
Cancer investigation 1990;8(5):509-21.
1989: John R Wingard; E D Mellits; Richard J Jones; W E Beschorner; M B Sostrin; W H Burns; G W Santos; R Saral
Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients.
Bone marrow transplantation 1989;4(6):685-9.
1989: Douglas A Jabs; John R Wingard; W Richard Green; Evan Farmer; Georgia B Vogelsang; R Saral
The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease.
Archives of ophthalmology 1989;107(9):1343-8.
1989: John R Wingard; Steven Piantadosi; Georgia B Vogelsang; Evan Farmer; D A Jabs; L S Levin; W E Beschorner; R A Cahill; D F Miller; D Harrison
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation.
Blood 1989;74(4):1428-35.
1989: S D Rowley; Richard J Jones; Steven Piantadosi; Hayden Braine; O Michael Colvin; JANICE DAVIS SPROUL; R Saral; Saul J Sharkis; John R Wingard; A M Yeager
Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
Blood 1989;74(1):501-6.
1989: R B Geller; R Saral; Steven Piantadosi; Marianna Zahurak; Georgia B Vogelsang; John R Wingard; Richard F Ambinder; W B Beschorner; Hayden Braine; W H Burns
Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia.
Blood 1989;73(8):2209-18.
1988: R B Geller; Georgia B Vogelsang; John R Wingard; A M Yeager; W H Burns; G W Santos; R Saral
Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1558-61.
1988: H K Holland; John R Wingard; W E Beschorner; R Saral; G W Santos
Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG.
Blood 1988;72(2):621-7.
1988: John R Wingard; M B Sostrin; H M Vriesendorp; E D Mellits; G W Santos; D J Fuller; Hayden Braine; A M Yeager; W H Burns; R Saral
Interstitial pneumonitis following autologous bone marrow transplantation.
Transplantation 1988;46(1):61-5.
1988: John R Wingard; E D Mellits; M B Sostrin; D Y Chen; W H Burns; G W Santos; huib vriesendorp; W E Beschorner; R Saral
Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution.
Medicine 1988;67(3):175-86.
1988: John R Wingard; D Y Chen; W H Burns; D J Fuller; Hayden Braine; A M Yeager; H Kaiser; PJ Burke; M L Graham; G W Santos
Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation.
Blood 1988;71(5):1432-7.
1987: G W Santos; R Saral; W H Burns; H G Braine; L L Sensenbrenner; John R Wingard; A M Yeager; Richard J Jones; Richard F Ambinder; S D Rowley
Allogeneic, syngeneic and autologous marrow transplantation in the acute leukemias and lymphomas--Baltimore experiences.
Acta haematologica 1987;78 Suppl 1():175-80.